PAYS
VENTE TOTALE: 259 904 titres (~2 768 002,76 $ US)
- Insiders
- Newcomer Mark, Herman Joan M
- Total bought
- —
- Total sold
- $2,768,003
- Last activity
- 2026-08-06
- Last synced
-
2026-08-12 09:47:22
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bullish signal Scored 2026-09-06
PAYS presents a compelling event-driven setup with record Q2 2026 revenue (+48%), a raised full-year outlook, and strong financial health scores (liquidity: 85, fundamentals trend: 75), supported by efficient working…
The first sentence of the analysis written for PAYS on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 49.2% | 55.1% | 51.1% | 55.1% | 49.9% | |
| Ebit Margin | 12.2% | 7.1% | 5.0% | -0.3% | -12.3% | |
| Ebitda Margin | 22.4% | 17.4% | 13.5% | 7.3% | -3.8% | |
| Operating Profit Margin | 8.8% | 1.7% | -0.4% | 0.9% | -9.3% | |
| Pretax Profit Margin | 12.2% | 7.1% | 5.0% | 3.0% | -9.2% | |
| Continuous Operations Profit Margin | 9.2% | 6.5% | 13.7% | 2.7% | -9.2% | |
| Net Profit Margin | 9.2% | 6.5% | 13.7% | 2.7% | -9.2% | |
| Bottom Line Profit Margin | 9.2% | 6.5% | 13.7% | 2.7% | -9.2% | |
| Current Ratio | 1.110 | 1.087 | 1.084 | 1.102 | 1.103 | |
| Quick Ratio | 1.110 | 1.087 | 1.084 | 1.102 | 1.103 | |
| Solvency Ratio | 0.070 | 0.066 | 0.086 | 0.043 | -0.003 | |
| Cash Ratio | 0.097 | 0.074 | 0.143 | 0.110 | 0.110 | |
| Price To Earnings Ratio | 36.786 | 42.120 | 23.333 | 130.303 | -29.963 | |
| Price To Earnings Growth Ratio | 0.386 | -1.046 | 0.046 | -0.951 | 0.417 | |
| Forward Price To Earnings Growth Ratio | 0.386 | -1.046 | 0.046 | -0.951 | 0.417 | |
| Price To Earnings Diluted Ratio | 39.615 | 44.023 | 23.333 | 132.990 | -29.963 | |
| Price To Earnings Diluted Growth Ratio | 0.443 | -1.028 | 0.045 | -0.976 | 0.417 | |
| Price To Book Ratio | 5.780 | 5.279 | 6.002 | 8.242 | 6.280 | |
| Price To Sales Ratio | 3.417 | 2.752 | 3.109 | 3.531 | 2.768 | |
| Price To Free Cash Flow Ratio | 5.470 | 11.940 | 7.144 | 6.326 | 6.500 | |
| Price To Operating Cash Flow Ratio | 5.344 | 7.002 | 5.321 | 5.304 | 5.356 | |
| Debt To Assets Ratio | 0.051 | 0.016 | 0.023 | 0.034 | 0.048 | |
| Debt To Equity Ratio | 0.289 | 0.096 | 0.135 | 0.225 | 0.309 | |
| Debt To Capital Ratio | 0.224 | 0.088 | 0.119 | 0.184 | 0.236 | |
| Long Term Debt To Capital Ratio | 0.112 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 5.697 | 5.881 | 5.987 | 6.643 | 6.472 | |
| Working Capital Turnover Ratio | 4.502 | 5.138 | 4.957 | 4.750 | 4.117 | |
| Operating Cash Flow Ratio | 0.242 | 0.157 | 0.232 | 0.286 | 0.226 | |
| Operating Cash Flow Sales Ratio | 0.639 | 0.393 | 0.584 | 0.666 | 0.517 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.977 | 0.586 | 0.745 | 0.838 | 0.824 | |
| Debt Service Coverage Ratio | 6.070 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 20.061 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 3.739 | 7.837 | 8.340 | 6.893 | 3.794 | |
| Capital Expenditure Coverage Ratio | 43.382 | 2.418 | 3.919 | 6.188 | 5.683 | |
| Dividend Paid And Capex Coverage Ratio | 43.382 | 2.418 | 3.919 | 6.188 | 5.683 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 14.890 | 15.084 | 20.857 | 45.898 | -69.937 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 49.2% | ▼-5.9% | ▼-2.9% |
| Ebit Margin | 12.2% | ▲5.1% | ▲9.9% |
| Ebitda Margin | 22.4% | ▲5.0% | ▲11.0% |
| Operating Profit Margin | 8.8% | ▲7.1% | ▲8.5% |
| Pretax Profit Margin | 12.2% | ▲5.1% | ▲8.6% |
| Continuous Operations Profit Margin | 9.2% | ▲2.7% | ▲4.6% |
| Net Profit Margin | 9.2% | ▲2.7% | ▲4.6% |
| Bottom Line Profit Margin | 9.2% | ▲2.7% | ▲4.6% |
| Current Ratio | 1.110 | ▲0.022 | ▲0.012 |
| Quick Ratio | 1.110 | ▲0.022 | ▲0.012 |
| Solvency Ratio | 0.070 | ▲0.004 | ▲0.017 |
| Cash Ratio | 0.097 | ▲0.024 | ▼-0.009 |
| Price To Earnings Ratio | 36.786 | ▼-5.334 | ▼-3.730 |
| Price To Earnings Growth Ratio | 0.386 | ▲1.433 | ▲0.616 |
| Forward Price To Earnings Growth Ratio | 0.386 | ▲1.433 | ▲0.616 |
| Price To Earnings Diluted Ratio | 39.615 | ▼-4.408 | ▼-2.385 |
| Price To Earnings Diluted Growth Ratio | 0.443 | ▲1.470 | ▲0.662 |
| Price To Book Ratio | 5.780 | ▲0.502 | ▼-0.536 |
| Price To Sales Ratio | 3.417 | ▲0.665 | ▲0.302 |
| Price To Free Cash Flow Ratio | 5.470 | ▼-6.469 | ▼-2.006 |
| Price To Operating Cash Flow Ratio | 5.344 | ▼-1.659 | ▼-0.321 |
| Debt To Assets Ratio | 0.051 | ▲0.034 | ▲0.017 |
| Debt To Equity Ratio | 0.289 | ▲0.193 | ▲0.078 |
| Debt To Capital Ratio | 0.224 | ▲0.137 | ▲0.054 |
| Long Term Debt To Capital Ratio | 0.112 | ▲0.112 | ▲0.090 |
| Financial Leverage Ratio | 5.697 | ▼-0.184 | ▼-0.439 |
| Working Capital Turnover Ratio | 4.502 | ▼-0.636 | ▼-0.190 |
| Operating Cash Flow Ratio | 0.242 | ▲0.085 | ▲0.014 |
| Operating Cash Flow Sales Ratio | 0.639 | ▲0.246 | ▲0.080 |
| Free Cash Flow Operating Cash Flow Ratio | 0.977 | ▲0.391 | ▲0.183 |
| Debt Service Coverage Ratio | 6.070 | ▲6.070 | ▲4.856 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 20.061 | ▲20.061 | ▲16.049 |
| Operating Cash Flow Coverage Ratio | 3.739 | ▼-4.098 | ▼-2.382 |
| Capital Expenditure Coverage Ratio | 43.382 | ▲40.964 | ▲31.064 |
| Dividend Paid And Capex Coverage Ratio | 43.382 | ▲40.964 | ▲31.064 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 14.890 | ▼-0.194 | ▲9.531 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $280.3M | $160.7M | $147.0M | $134.3M | $81.6M | |
| Enterprise value | $273.3M | $152.8M | $133.3M | $128.2M | $78.2M | |
| EV / Sales | 3.33x | 2.62x | 2.82x | 3.37x | 2.65x | |
| EV / Op. cash flow | 5.21x | 6.66x | 4.83x | 5.07x | 5.13x | |
| EV / Free cash flow | 5.33x | 11.36x | 6.48x | 6.04x | 6.23x | |
| EV / EBITDA | 14.89x | 15.08x | 20.86x | 45.90x | -69.94x | |
| Net debt / EBITDA | -0.38x | -0.77x | -2.14x | -2.16x | 3.02x | |
| Current ratio | 1.11x | 1.09x | 1.08x | 1.10x | 1.10x | |
| Income quality | 6.95x | 6.01x | 4.28x | 24.63x | -5.60x | |
| Graham number | $2 | $1 | $1 | $0 | — | |
| Graham net-net | -$3 | -$2 | -$2 | -$2 | -$1 | |
| Tax burden | 75.3% | 92.2% | 273.2% | 90.5% | 100.4% | |
| Interest burden | 100.0% | 100.0% | 100.0% | -983.6% | 75.0% | |
| Working capital | $23.7M | $12.7M | $10.0M | $9.1M | $6.9M | |
| Invested capital | $58.2M | $28.9M | $23.1M | $19.6M | $16.7M | |
| Return on assets | 2.7% | 2.1% | 4.4% | 0.9% | -3.2% | |
| Operating ROA | 3.2% | 0.6% | -0.1% | 0.4% | -3.6% | |
| Return on tangible assets | 3.0% | 2.3% | 4.7% | 1.0% | -3.4% | |
| Return on equity | 15.6% | 12.5% | 26.4% | 6.3% | -21.0% | |
| Return on invested capital | 8.7% | 2.8% | -0.6% | 1.6% | -16.1% | |
| Return on capital employed | 12.1% | 3.1% | -0.6% | 1.8% | -16.4% | |
| Earnings yield | 2.7% | 2.4% | 4.4% | 0.8% | -3.3% | |
| Free cash flow yield | 18.3% | 8.4% | 14.0% | 15.8% | 15.4% | |
| Capex / Op. cash flow | 2.3% | 41.4% | 25.5% | 16.2% | 17.6% | |
| Capex / Depreciation | 14.5% | 158.3% | 175.1% | 140.6% | 107.3% | |
| Capex / Sales | 1.5% | 16.3% | 14.9% | 10.8% | 9.1% | |
| SG&A / Sales | 40.4% | 43.1% | 42.9% | 47.7% | 53.7% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 5.2% | 4.5% | 6.0% | 6.0% | 7.7% | |
| Intangibles / Total assets | 9.7% | 6.8% | 6.0% | 5.2% | 4.9% | |
| Days sales outstanding | 325d | 214d | 125d | 45d | 42d | |
| Days payables outstanding | 618d | 478d | 418d | 173d | 143d | |
| Operating cycle | 325d | 214d | 125d | 45d | 42d | |
| Cash conversion cycle | -293d | -264d | -293d | -128d | -101d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+74.4%EV / Sales ▲+27.2%EV / EBITDA ▼-1.3%EV / Op. cash flow ▼-1.451Earnings yield ▲+0.003Graham number ▲+0.707
Profitability
Return on equity ▲+0.030Return on assets ▲+0.006Return on invested capital ▲+0.059Return on capital employed ▲+0.090Operating ROA ▲+0.026Income quality ▲+0.932Tax burden ▼-0.169
Efficiency
Days sales outstanding ▲+111.264Days payables outstanding ▲+140.001Operating cycle ▲+111.264Cash conversion cycle ▼-28.737Capex / Sales ▼-0.148R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.022Net debt / EBITDA ▲+0.390Working capital ▲+10978323.000Invested capital ▲+29248992.000Intangibles / Total assets ▲+0.029
Change over 5 years
Valuation
Market cap ▲+243.7%EV / Sales ▲+25.5%EV / EBITDA ▲+121.3%EV / Op. cash flow ▲+0.075Earnings yield ▲+0.060
Profitability
Return on equity ▲+0.365Return on assets ▲+0.060Return on invested capital ▲+0.248Return on capital employed ▲+0.285Operating ROA ▲+0.068Income quality ▲+12.542Tax burden ▼-0.251
Efficiency
Days sales outstanding ▲+283.312Days payables outstanding ▲+475.857Operating cycle ▲+283.312Cash conversion cycle ▼-192.545Capex / Sales ▼-0.076R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.007Net debt / EBITDA ▼-3.401Working capital ▲+16771070.000Invested capital ▲+41508756.000Intangibles / Total assets ▲+0.049
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-10 3 Reasons Growth Investors Will Love Paysign (PAYS) Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 2026-08-06 Paysign Q2 Earnings Call Highlights Paysign NASDAQ: PAYS reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utilization in its plasma donor compensation operations.
- 2026-08-05 Paysign, Inc. (PAYS) Q2 2026 Earnings Call Transcript Paysign, Inc. (PAYS) Q2 2026 Earnings Call Transcript
- 2026-08-05 Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive pharma patient affordability offerings, financial technology products and integrated payment processing, today announced financial results for the second quarter 2026. “Paysign delivered a strong second quarter, achieving record revenue, net income, and adjusted EBITDA while continuing to expand margins,” said Mark Newcomer, President and CEO of Paysign. “Strong growth in o.
- 2026-07-14 Paysign to Host Second Quarter 2026 Earnings Call HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss second quarter 2026 earnings at 5:00 p.m. Eastern time on Wednesday, August 5, 2026. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.68.
- 2026-06-02 Paysign, Inc. to Present at the Planet MicroCap Las Vegas 2026 Paysign, Inc. (NASDAQ: [url="]PAYS[/url]), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platfo
- 2026-06-02 Paysign, Inc. to Present at the Planet MicroCap Las Vegas 2026 HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Planet MicroCap Las Vegas 2026.
- 2026-05-27 Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference Paysign, Inc. (NASDAQ: [url="]PAYS[/url]), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platfo
- 2026-05-27 Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference.
- 2026-05-13 Paysign, Inc. (PAYS) Q1 2026 Earnings Call Transcript Paysign, Inc. (PAYS) Q1 2026 Earnings Call Transcript